Rus Eng
Main / Company's news / Moscow Discusses Development of Russian Drug Production

Moscow Discusses Development of Russian Drug Production

18 February 2014

On 10 February, the first Adam Smith Conference devoted to production of pharmaceuticals in Russia and CIS countries was held in Moscow. This topic became a particularly relevant due to an intensive progress in modernizing the industry and the transition to international GMP standards. The experts at the conference covered a wide range of issues which included new regulatory principles of the industry, practical aspects of the localization of high-tech facilities, and qualified personnel for production cycles.

Central session of the conference was Maintaining and Ensuring a High Level of Operational Activity in the Pharmaceutical Production Sector which gathered as speakers quality directors of leading local pharmaceutical companies. Quality Director of GEROPHARM, Group of Companies Natalia Novichkova shared the implementation experience of GMP standards in the new plant and basic approaches. In October 2013, a modern GEROPHARM-Bio plant (a part of GEROPHARM, Group of Companies) was commissioned and officially opened in the Moscow region on which the GMP standards were introduced before they became mandatory in Russia.

A solid practical experience in arranging all processes in accordance with international standards allowed to combine corporate knowledge and competences in 10 Golden Rules which Natalia shared with the audience. Each of these rules is aimed at achieving and maintaining the highest level of quality at every stage of production which is one of the company’s priority. “We believe the quality is the foundation on which everything is built,” says Natalia. “And we remember that we work for people by helping them to maintain a high quality of life.”

The industry colleagues recognize that the speech of the representative of GEROPHARM made an effective contribution to the overall dialogue of experts which demonstrates that, despite the existing difficulties of the transition period for the industry as a whole, the leading Russian pharmaceutical manufacturers are not only ready for the transition to international standards, but also successfully arranged their work in accordance with that standards.

You are a health care professional?

Go up